Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
Revenue of Adicet Bio, Inc. (ACET)
Revenue in 2023 (TTM): $
According to Adicet Bio, Inc.'s latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Adicet Bio, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $ | $-6,098,000 | $-136,535,000 | $-142,658,000 | $-142,658,000 |
| 2022 | $24.99 M | $19.98 M | $-64,701,000 | $-69,790,000 | $-67,029,000 |
| 2021 | $9.73 M | $9.73 M | $-60,410,000 | $-62,124,000 | $-61,999,000 |
| 2020 | $17.9 M | $17.9 M | $-37,408,000 | $-39,493,000 | $-36,678,000 |
| 2019 | $995 K | $870 K | $-26,881,000 | $-28,119,000 | $-28,138,000 |
| 2018 | $8.18 M | $8.1 M | $-13,742,000 | $-9,888,000 | $-9,299,000 |
| 2017 | $558.52 M | $558.52 M | $-33,773,000 | $-33,778,000 | $-33,778,000 |
| 2016 | $546.95 M | $135.43 M | $-1,000 | $-1,000 | $-1,000 |
| 2015 | $510.18 M | $114.7 M | $54.87 M | $44.67 M | $29 M |
| 2014 | $499.69 M | $98.27 M | $43.62 M | $34.55 M | $22.33 M |
| 2013 | $499.69 M | $98.27 M | $43.62 M | $34.55 M | $22.33 M |
| 2012 | $444.39 M | $82.03 M | $34.31 M | $24.74 M | $16.98 M |
| 2011 | $412.43 M | $65.84 M | $24.03 M | $16.96 M | $8.97 M |
| 2010 | $346.63 M | $54.16 M | $13.23 M | $10.2 M | $6.58 M |
| 2009 | $322.65 M | $55.62 M | $14.7 M | $12.73 M | $8.63 M |
| 2008 | $359.59 M | $67.31 M | $24.71 M | $22.19 M | $13.47 M |